UmweltBank — Awaiting an earnings inflection point

UmweltBank — Awaiting an earnings inflection point

UmweltBank’s (UBK’s) preliminary FY18 numbers confirm the continuation of healthy lending business and deposit base growth, but also further interest margin compression. The additional tier 2 capital raised recently (€45m in total) provides a solid foundation for further loan book expansion, which together with gradually diminishing pressure on margins could translate into UBK’s earnings momentum turning positive in 2020. The planned launch of new products in 2019 and 2020 (such as the sustainable consumer credit) may provide some additional tailwinds, but may also translate into a temporarily higher cost income ratio (CIR).

Milosz Papst

Written by

Milosz Papst

Director, Financials

UmweltBank

Awaiting an earnings inflection point

FY18 preliminary results

Banks

14 February 2019

Price

€8.74

Market cap

€244m

Total assets (€bn) at end-2018

3.7

Shares in issue

27.9m

Free float

84.4%

Code

UBKX

Primary exchange

Munich

Secondary exchange

Xetra

Share price performance

%

1m

3m

12m

Abs

1.2

0.5

(18.9)

Rel (local)

(1.4)

3.2

(11.4)

52-week high/low

€11.1

€7.7

Business description

UmweltBank is a specialised lender with total assets of €3.7bn, providing financing of renewable energy projects (solar, wind, hydro and biomass), as well as loans for new construction or renovation of sustainable residential, community and commercial real estate.

Next events

FY18 report

May 2019

AGM

27 June 2019

H119 results

August 2019

Analyst

Milosz Papst

+44 (0)20 3077 5700

UmweltBank is a research client of Edison Investment Research Limited

UmweltBank’s (UBK’s) preliminary FY18 numbers confirm the continuation of healthy lending business and deposit base growth, but also further interest margin compression. The additional tier 2 capital raised recently (€45m in total) provides a solid foundation for further loan book expansion, which together with gradually diminishing pressure on margins could translate into UBK’s earnings momentum turning positive in 2020. The planned launch of new products in 2019 and 2020 (such as the sustainable consumer credit) may provide some additional tailwinds, but may also translate into a temporarily higher cost income ratio (CIR).

Year end

Net interest
income (€m)

EPS*
(€)

DPS
(€)

P/BV*
(x)

P/E*
(x)

ROE*
(%)

Yield
(%)

12/17

52.2

0.99

0.32

1.2

8.8

13.7

3.7

12/18e**

50.7

0.90

0.34

1.1

9.7

11.5

3.9

12/19e

50.6

0.85

0.36

1.0

10.3

10.1

4.1

12/20e

52.7

0.88

0.38

1.0

9.9

9.9

4.3

Note: *Based on net profit before allocation to reserves for general banking risks and tangible book value including reserves for general banking risks ** Edison estimate based on preliminary numbers

Continued interest margin pressure in FY18

UBK reported an 8.4% y-o-y decline in net profit before reserves allocation to €25.3m, which is c 3% below our estimates. This has been a function of lower net interest and financial income, which was partially driven by the continued pressure on interest margins in line with the trend seen in recent years across the sector. G&A expenses (ex-D&A) increased by 10.0% y-o-y to €17.8m due to headcount expansion and higher banking tax and deposit insurance costs. This translated into a CIR at 32.9% vs 29.4% in FY17, broadly in line with our expectations (33.0%).

Solid lending activity and strengthened capital base

UBK’s new lending volumes improved 26.3% y-o-y to €542m, assisted to a similar extent by renewable energy projects and green construction. In conjunction with the growth in the bank’s irrevocable lending commitments, the overall sustainable loan book went up by 8.6% y-o-y to €2.9bn. Meanwhile, UBK was able to raise €45m of fresh tier 2 capital from the ongoing Green Bond Junior issue, as well as a subordinated bond placement to an institutional investor. We believe that UBK now has c €0.4bn balance sheet headroom (in risk-weighted assets terms) for its loan portfolio growth (which represents c 17% of current customer loan book) even without taking into account future profits accumulation and new capital.

Valuation: Trading at par with book value

UBK’s shares are trading at a FY19e P/BV ratio of 1.0x (vs peer average of 1.1x), which in our opinion does not fully reflect its earnings potential once the bank returns to its bottom-line growth path. We have slightly lowered our FY19e and FY20e forecasts, but kept our long-term assumptions broadly unchanged. Thus we have retained our fair value estimate of UBK at €11.3 per share, which implies a 30% upside potential. At the current share price, UBK’s dividend yield stands at c 4% vs average level for large banks at c 4.4%.

FY18 results: Volumes up, interest margin down

UBK’s FY18 preliminary results show continued solid lending business and customer deposit base growth, accompanied by persistent earnings pressures translating into a declining net interest margin (NIM). The bank’s new lending volumes reached an encouraging €542m in FY18 (of which €311m in H118), up 26.3% from €429m reported in FY17 (see Exhibit 1). Importantly, this has been driven equally by sustainable construction and green projects, in particular smaller solar projects of up to 750kW (which are not subject to the auction system and are still entitled to receive a fixed feed-in tariff), but also wind projects, of which a significant part represent those that participated in the earlier auctions. This is important given that the number of submitted bids in these auctions was higher than in the most recent tenders, when bottlenecks related to prolonged regulatory approval times started to become visible. Consequently, UBK’s loan book (including commitments) reached €2.9bn, up c 8.6% vs FY17. Simultaneously, customer deposits increased by a strong 8.0% y-o-y (vs our estimate of 7.5% y-o-y).

Net interest and financial income decreased 5.3% y-o-y in FY18 to €51.9m and was c 6% below our estimates. This figure includes several P&L items, including net interest income, net financial income excluding net trading income and provisions for credit losses and the impact of net valuation changes. UBK has not provided the corresponding breakdown in its press release, but has shared some supplementary information in its announcement, which suggests that the decline in net interest margin was somewhat less pronounced than in FY17 (and slightly stronger versus our expectations). In this context, it is important to note that UBK’s H118 results were assisted by early repayment fees on two sizeable loans (we estimate the impact at around €0.5–1.0m). Net commission and fee expense declined by 13% y-o-y to €2.6m in FY18 amid the lack of arrangement fees (as current market conditions make it difficult for UBK to charge those), as well as the change in recognition of distribution fees related to equity funds, now booked under net trading income.

With the ongoing expansion of the team (172 employees at end-2018 compared with 153 at end-2017), personnel expenses grew by 14.1% y-o-y to €9.2m (close to our growth estimate of 11% y-o-y). Other administrative expenses increased by only 5.9% y-o-y to €8.5m, predominantly on the back of higher banking tax and deposit insurance in conjunction with the healthy customer deposits growth. We suspect that some expenses related to the sustainable consumer credit product were pushed beyond 2018, as the product launch was postponed until 2019. As a result, CIR reached 32.9% in FY18 (broadly in line with our forecast at 33.0%). FY18 results were also supported by net other operating income of €571k (compared with net operating expense of €1.4m in FY17), which we understand was driven by provision reversals.

Consequently, pre-tax profit was down 7.4% y-o-y to €37.3m vs our expectations of a 4.2% y-o-y decline to €38.6m. Net income after allocation of reserves for general banking risks stood at €16.9m and was up 1.6% y-o-y. However, it must be noted that the amount allocated to reserves is determined by the management board and usually adjusted to smooth out bottom-line growth in the long term. In fact, earnings before allocation of reserves fell by 8.4% y-o-y to €25.3m.

Exhibit 1: FY18 preliminary results review

€000s, unless otherwise stated

FY18

FY17

change y-o-y

FY18e

diff

Net interest, financial and net valuation income*

51,893

54,819

-5.3%

55,369

-6.3%

Net commissions and fee expense

2,605

2,994

-13.0%

2,253

15.6%

G&A expenses (ex-D&A)

(17,758)

(16,144)

10.0%

(18,303)

-3.0%

Personnel expenses

(9,221)

(8,084)

14.1%

(8,990)

2.6%

Other administrative expenses

(8,537)

(8,060)

5.9%

(9,313)

-8.3%

thereof, banking tax and deposit insurance

(1,849)

(1,387)

33.3%

(1,941)

-4.8%

Other operating income (expense)

571

(1,395)

n.m.

(429)

n.m.

Pre-tax profit

37,311

40,274

-7.4%

38,565

-3.3%

Income taxes

(11,975)

(12,612)

-5.1%

(12,379)

-3.3%

Effective tax rate

32.1%

31.3%

78 bps

32.1%

0 bps

Net income (before reserves allocation)

25,336

27,662

-8.4%

26,186

-3.2%

 

 

 

 

 

 

New lending volume (€m)

542

429

26.3%

N/A

N/A

Business volume (€m)

4,123

3,766

9.5%

4,067

1.4%

Customer deposits (€m)

2,330

2,157

8.0%

2,319

0.5%

Total assets (€m)

3,699

3,485

6.1%

3,687

0.3%

Equity (€m)

333

282

18.1%

332

0.4%

Total capital adequacy ratio (TCR)

14.0%

12.4%

160bp

13.6%

40bp

CET1 ratio

9.3%

8.9%

40bp

9.1%

23bp

Cost Income Ratio (CIR)

32.9%

29.4%

350bp

33.0%

-11bp

Source: UmweltBank, Edison Investment Research. Note: *Including provisions for credit losses, net financial income (excl. net trading income) and the impact of net valuation changes.

New tier 2 capital from €45m of subordinated debt

To strengthen its capital base and facilitate further loan portfolio growth, the bank launched the issue of its 2.0% unsecured subordinated bond (Green Bond Junior) in July last year. So far UBK was able to raise €25m in proceeds (as per the press release dated 4 February). Based on our discussion with the management, we understand that c €13.2m of this amount represents the result of exchange offers to holders of UBK’s profit participation rights (Genussrechte) issued in the period 2003–05 and 2006 (see our previous update note for details). This implies that c 70% of the eligible profit participation rights were exchanged, while the remaining securities were already called and redeemed by the bank (as they were about to lose their tier 2 capital status soon anyway). The remaining c €12m was subscribed for by other retail investors. The issue is still ongoing and will be concluded in July 2019, which means UBK may still raise up to €15m of incremental tier 2 capital (we conservatively assume €10m in our forecasts). Moreover, the bank has raised an additional €20m through the issue of subordinated debt to an institutional investor.

As a result, UBK was able to increase its TCR to 14.0% from 12.5% at end-June 2018 and 12.4% at end-2017. We estimate that this translates into c €0.4bn (or c 17% of current customer loan book) of balance sheet headroom for further loan portfolio growth (in risk-weighted asset terms). This does not account for net profit accumulated or new capital issues. Additionally, UBK is strengthening its capital base through scrip dividends introduced in 2017, which contributed €3m of new capital in 2018. Finally, management still considers a share issue to further improve the CET1 ratio and potentially allow for a reduction of UBK’s special buffer (1.5%) added by the German regulator on top of the standard Basel III TCR requirement of 10.5% applied in 2019.

Outlook and forecast revisions

Our forecast revisions are summarised in Exhibit 2. As we believe the decline in UBK’s net interest margin was only slightly more pronounced than we have originally anticipated, we have marginally reduced our NIM expectations for FY19e and FY20e by 6bp and 5bp, respectively. In our opinion, this translates into relatively conservative estimates, given that the management’s neutral scenario assumes that the interest margin should flatten out from FY19e onwards. This is supported by the fact that the interest rate on UBK’s loans is usually fixed for 10 years (and subsequently adjusted for market rate movements). As the ECB interest rate cuts were executed over 2008–2012, most of it should be reflected in UBK’s interest income by 2020/2021. Moreover, the prospective ECB rate hikes (even if their exact timing is hard to predict) should assist UBK’s income on floating rate assets and new sustainable loans.

Similarly, UBK remains on its growth path with respect to loan book and deposit base, even if we acknowledge that a significant proportion of the business volume growth was attributable to irrevocable lending commitments rather than finalised loans. Moreover, the development of onshore wind projects in Germany is subject to bottlenecks related to extended regulatory requirements and approval timelines, a deficit of approved regional plans and an increase in legal actions against capacity allotments during already closed auctions. However, it seems that UBK’s pipeline of project financing is full at the moment. Also, we believe the bank’s lending activity in the smaller photovoltaic projects segment (which also command a higher interest margin) may potentially offset more muted new lending volumes in the wind segment. The delay in sustainable consumer credit launch (initially planned until end-2018, now expected in 2019) will not impact our forecasts materially, as the proportion of loan book growth attributable to the consumer credit we have pencilled in for FY19e was negligible. Hence, we introduce only minor changes to our forecasts of new lending volumes and new customer deposits.

Based on our discussions with the company, we understand that in 2019 UBK intends to be more active in corporate fixed income securities, where it is experiencing increased customer interest. Consequently, we have raised our net commissions and fee expense estimates accordingly, assuming a few small to mid-sized transactions executed per year. We have increased our G&A expense expectations in FY19e and FY20e by c 6.5% and 2.5%, respectively, assuming that some expenses related to the newly launched products might have been postponed last year. As a result, we expect the CIR ratio to go up to 37.3% in FY19e and 36.0% in FY20e. Our UBK share valuation remains unchanged at €11.3 per share, as our long-term forecasts (i.e. beyond 2020) remain broadly unchanged.

Exhibit 2: Forecast revisions table

€000s

2018

2019e

2020e

 

 

Old

New

Change

y-o-y

Old

New

Change

y-o-y

Net interest, financial
and net valuation income*

51,893

54,294

52,905

-2.6%

2.0%

55,752

54,719

-1.9%

3.4%

Net commissions and fee expense**

2,605

2,274

3,374

48.4%

29.5%

2,341

3,497

49.4%

3.6%

Pre-tax profit

37,311

36,788

35,465

-3.6%

-4.9%

37,538

37,386

-0.4%

5.4%

Net income (before allocation to reserves)

25,336

25,200

24,294

-3.6%

-4.1%

25,714

25,610

-0.4%

5.4%

Customer loans (excl. commitments)

N/A

2,554,801

2,540,333

-0.6%

N/A

2,672,608

2,697,261

0.9%

6.2%

Customer deposits

2,330,000

2,434,719

2,446,500

0.5%

5.0%

2,556,455

2,568,825

0.5%

5.0%

CET1 ratio (%)

9.3

9.6

9.5

-11 bps

24 bps

10.0

9.9

-10 bps

36 bps

Tier-1 ratio (%)

N/A

10.9

10.8

-11 bps

N/A

11.1

11.0

-11 bps

26 bps

TCR (%)

14.0

14.1

14.4

33 bps

41 bps

14.3

14.6

31 bps

19 bps

CIR (%)

32.9 

34.9

37.3

232 bps

436 bps

35.4

36.0

66 bps

-123 bps

Source: UmweltBank, Edison Investment Research; Note: *Including provisions for credit losses, net financial income (excl. net trading income) and the impact of net valuation changes. **Includes net trading income.

We estimate UBK’s ROE in FY19e at 10.1%, which compares with an average ratio for listed banks from the DACH region at 9.1% (based on Refinitiv consensus). We note that UBK’s FY19e ratio is below our long-term sustainable ROE estimate of c 11.7% due to depressed NIM (which may bottom out soon though as discussed above) and higher OPEX amid the launch of new products. At the same time, UBK’s FY19e P/BV stands at 1.0x, slightly below peer average of 1.1x (see Exhibit 3).

Exhibit 3: UmweltBank’s P/BV and ROE 2019e comparison versus peers

Source: Refinitiv, Edison Investment Research. Note: Ratios for UmweltBank are based on net profit before reserves allocation and book value including balance sheet value of reserves for general banking risks.

Exhibit 4: Financial summary

Year Ending

2014

2015

2016

2017

2018e*

2019e

2020e

2021e

2022e

INCOME STATEMENT

 

 

 

 

 

 

 

 

 

Net interest income

49,153

52,838

53,600

52,166

50,740

50,560

52,730

56,554

60,275

Net financial income

1,972

4,023

5,937

2,909

2,831

3,396

3,591

3,721

3,851

Net interest and financial income

51,125

56,861

59,537

55,075

53,571

53,957

56,321

60,275

64,126

Provisions (-)

638

443

(2,228)

(355)

(1,368)

(864)

(1,415)

(1,499)

(1,549)

Total administrative expenses

(12,024)

(13,163)

(15,563)

(16,466)

(18,082)

(20,614)

(20,629)

(20,531)

(20,924)

Earnings before administrative costs and taxes

56,130

61,340

61,570

56,739

55,394

56,079

58,015

62,025

65,956

PBT

44,106

48,177

46,007

40,274

37,311

35,465

37,386

41,494

45,033

Net profit after tax

27,542

34,087

32,155

27,661

25,336

24,294

25,610

28,423

30,847

Reported EPS

0.53

0.56

0.58

0.60

0.60

0.62

0.64

0.66

0.68

Adjusted EPS

0.99

1.23

1.16

0.99

0.90

0.85

0.88

0.96

1.03

DPS

0.26

0.28

0.34

0.32

0.34

0.36

0.38

0.40

0.42

BALANCE SHEET

 

 

 

 

 

 

 

 

 

Cash and balances at Central Banks

36,910

33,171

54,591

32,460

47,017

47,448

59,738

101,412

151,938

Claims on banks

294,248

321,602

149,281

122,622

122,622

100,724

82,737

67,961

55,825

Claims on customers

1,876,476

2,098,150

2,229,817

2,273,561

2,377,999

2,540,333

2,697,261

2,852,625

3,003,741

Bonds and other fixed-interest securities

373,146

288,437

747,214

1,023,677

1,146,518

1,146,518

1,135,053

1,101,001

1,067,971

Tangible assets, Goodwill and Intangible assets

729

759

1,174

1,202

1,202

1,202

1,202

1,202

1,202

Other assets

13,903

15,553

24,165

31,479

35,479

39,479

41,479

43,479

45,479

Total assets

2,595,412

2,757,672

3,206,242

3,485,001

3,730,838

3,875,705

4,017,471

4,167,681

4,326,156

Liabilities to banks

572,399

570,938

860,728

1,011,950

1,042,308

1,042,308

1,042,308

1,042,308

1,042,308

Liabilities to customers

1,808,041

1,938,174

2,055,684

2,157,005

2,330,000

2,446,500

2,568,825

2,697,266

2,832,130

Accruals and deferred expense

510

1,440

1,220

1,012

839

695

577

478

396

Deferred tax liabilities

0

0

231

148

148

148

148

148

148

Other liabilities

132,824

157,095

189,952

206,873

239,152

256,015

263,578

273,123

284,163

Total liabilities

2,513,774

2,667,647

3,107,816

3,376,987

3,612,447

3,745,667

3,875,436

4,013,324

4,159,145

Total shareholders' equity

81,638

90,025

98,426

108,013

118,390

130,038

142,034

154,357

167,011

BVPS

2.9

3.3

3.6

3.9

4.2

4.5

4.9

5.2

5.5

TNAV per share

5.1

6.0

6.9

7.6

8.1

8.6

9.2

9.7

10.3

Ratios

 

 

 

 

 

 

 

 

 

NIM

1.98%

2.06%

1.87%

1.62%

1.47%

1.39%

1.40%

1.45%

1.49%

Costs/Income

21.5%

22.0%

26.9%

29.4%

32.9%

37.3%

36.0%

33.5%

32.1%

ROE

21.3%

22.2%

18.0%

13.7%

11.5%

10.1%

9.9%

10.2%

10.3%

CET1 Ratio

7.5%

8.1%

8.5%

8.9%

9.3%

9.5%

9.9%

10.3%

10.7%

Tier 1 ratio

8.2%

8.7%

9.9%

10.4%

10.7%

10.8%

11.0%

11.3%

11.6%

Capital adequacy ratio

10.8%

11.0%

12.0%

12.4%

14.0%

14.4%

14.6%

14.8%

15.0%

Payout ratio (%)

26.1%

22.7%

29.3%

32.3%

38.0%

42.6%

43.4%

41.9%

41.2%

Customer loans/Total assets

72.3%

76.1%

69.5%

65.2%

63.7%

65.5%

67.1%

68.4%

69.4%

Loans/Deposits

103.8%

108.3%

108.5%

105.4%

102.1%

103.8%

105.0%

105.8%

106.1%

Source: UmweltBank, Edison Investment Research. Note: *Edison estimates based on preliminary numbers.


General disclaimer and copyright

This report has been commissioned by UmweltBank and prepared and issued by Edison, in consideration of a fee payable by UmweltBank. Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the Edison analyst at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2019 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2019. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Myonlineadvisers Pty Ltd who holds an Australian Financial Services Licence (Number: 427484). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

Neither this document and associated email (together, the "Communication") constitutes or form part of any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any securities, nor shall it or any part of it form the basis of, or be relied on in connection with, any contract or commitment whatsoever. Any decision to purchase shares in the Company in the proposed placing should be made solely on the basis of the information to be contained in the admission document to be published in connection therewith.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document (nor will such persons be able to purchase shares in the placing).

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

The Investment Research is a publication distributed in the United States by Edison Investment Research, Inc. Edison Investment Research, Inc. is registered as an investment adviser with the Securities and Exchange Commission. Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a) (11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

General disclaimer and copyright

This report has been commissioned by UmweltBank and prepared and issued by Edison, in consideration of a fee payable by UmweltBank. Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the Edison analyst at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2019 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2019. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Myonlineadvisers Pty Ltd who holds an Australian Financial Services Licence (Number: 427484). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

Neither this document and associated email (together, the "Communication") constitutes or form part of any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any securities, nor shall it or any part of it form the basis of, or be relied on in connection with, any contract or commitment whatsoever. Any decision to purchase shares in the Company in the proposed placing should be made solely on the basis of the information to be contained in the admission document to be published in connection therewith.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document (nor will such persons be able to purchase shares in the placing).

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

The Investment Research is a publication distributed in the United States by Edison Investment Research, Inc. Edison Investment Research, Inc. is registered as an investment adviser with the Securities and Exchange Commission. Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a) (11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Research: Healthcare

InMed Pharmaceuticals — Entering the clinic by the end of the year

InMed recently reported results for the second quarter of FY19 and is on track to bring INM-750 for epidermolysis bullosa (EB) into the clinic by the end of the year. The company recently completed two topical seven-day dose-ranging studies in pigs; the trials evaluated skin irritation, pharmacokinetics, histology and skin/drug concentrations and InMed is on the verge of selecting the contract manufacturing organization that will produce the topical cream necessary for the Phase I trial. Progress on biosynthesis continues as the company has initiated technology transfer activities to the National Research Council Canada (NRC), which will support fermentation scale-up.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free